CRISPR

CRISPR1-myh7,myh7l

ID
ZDB-CRISPR-221207-1
Name
CRISPR1-myh7,myh7l
Previous Names
None
Targets
Sequence
5' - GAATGAGGGTGAGTTGACCTT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
No data available
Expression
Gene expression in Wild Types + CRISPR1-myh7,myh7l
Phenotype
Phenotype resulting from CRISPR1-myh7,myh7l
No data available
Phenotype of all Fish created by or utilizing CRISPR1-myh7,myh7l
Phenotype Fish Conditions Figures
cardiac ventricle myh7l expression decreased amount, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
pericardium edematous, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
whole organism decreased life span, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
cardiac ventricle mylk3 expression decreased amount, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
whole organism dead, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
cardiac ventricle development disrupted, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
heart contraction disrupted, abnormal WT + CRISPR1-myh7,myh7l standard conditions Fig. SVideo1 from Hesaraki et al., 2022
heart blood circulation disrupted, abnormal WT + CRISPR1-myh7,myh7l standard conditions Fig. SVideo1 from Hesaraki et al., 2022
cardiac ventricle myh7 expression decreased amount, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
pericardial cavity myh7 expression mislocalised, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
cardiac atrium development disrupted, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
cardiac ventricle myh7 expression increased distribution, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
yolk syncytial layer edematous, abnormal WT + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
heart tubular, abnormal ka8Tg + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
cardiac ventricle increased thickness, abnormal ka8Tg + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
heart looping disrupted, abnormal ka8Tg + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
atrium increased size, abnormal ka8Tg + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
cardiac ventricle increased size, abnormal ka8Tg + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
cardiac ventricle elongated, abnormal ka8Tg + CRISPR1-myh7,myh7l standard conditions Figure 4 with image from Hesaraki et al., 2022
Citations